Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine-rich protein 1 pseudogene 3 (CRIP1P3) is a processed pseudogene of the cysteine-rich protein 1 (CRIP1) gene. Pseudogenes are genomic sequences related to functional genes that have lost their protein-coding ability due to mutations or lack of regulatory sequences and are widely categorized as nonfunctional vestiges by default[2][4]. However, a subset of pseudogenes, especially when transcribed, may act as regulatory non-coding RNAs with biological significance, sometimes modulating their parental gene or participating in molecular networks through mechanisms such as microRNA sponging[2][4]. There is currently *no evidence* that CRIP1P3 produces a protein or directly participates in known biological pathways, nor is it a recognized drug or disease target. Its primary significance, if any, would be non-coding RNA-mediated regulation, which is a potential area of ongoing research but not established for this specific locus. CRIP1P3 is **not a therapeutic target**. It is an **unprocessed pseudogene** (non-functional for protein-coding), and currently, no drugs interact with it. The canonical abbreviation is **CRIP1P3**; full name is **cysteine-rich protein 1 pseudogene 3**. No data support direct disease involvement or biomarker status for this pseudogene—any regulatory role is unconfirmed and would be limited to RNA-level effects[2][4].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine-rich protein 1 pseudogene 3 (CRIP1P3).